AI assistant
Sending…
EXPONENT INC — Director's Dealing 2016
May 27, 2016
31263_dirs_2016-05-27_4a87ce89-5284-48dd-8397-58f97447a4d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXPONENT INC (EXPO)
CIK: 0000851520
Period of Report: 2016-05-25
Reporting Person: SHOVEN JOHN B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-25 | Common Stock | M | 2354.0 | — | Acquired | 27514 | Direct |
| 2016-05-25 | Common Stock | M | 32.0 | — | Acquired | 27546 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-25 | Dividend Equivalent Rights | $ | A | 9.0 | Acquired | 2016-05-25 | Common Stock (9) | Direct |
| 2016-05-25 | Dividend Equivalent Rights | $ | M | 32.0 | Disposed | 2016-05-25 | Common Stock (32) | Direct |
| 2016-05-25 | Restricted Stock Units | $ | M | 2354.0 | Disposed | Common Stock (2354) | Direct | |
| 2016-05-26 | Restricted Stock Units | $ | A | 2146.0 | Acquired | Common Stock (2146) | Direct |
Footnotes
F1: Reflects the conversion of shares of vested Restricted Stock Units granted on May 28, 2015 into shares of Common Stock on a 1:1 basis.
F2: Not applicable.
F3: Settlement of dividend equivalent rights in connection with RSU release on a 1:1 basis.
F4: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in Q1 2016.
F5: 1-for-1.
F6: Restricted stock units will cliff-vest on the day prior to the Company's next annual shareholder meeting.
More from EXPONENT INC
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 20
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 27